Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Another Miss For LAG-3 In MSS Colorectal Cancer In Keytruda Combo Study

26 Sep 2024

• By Kevin Grogan

dart — • Source: Shutterstock

Related Content

BMS Wins Competition For Novel Checkpoint Inhibitors With Relatlimab Approval

21 Mar 2022

Regeneron’s Libtayo/Fianlimab LAGs Bristol’s Opdualag On Timing, But May Win On Efficacy

08 Jun 2023

Immutep LAG-3 Inhibitor May Have Path Forward

12 Jul 2024

Related Companies

Merck & Co., Inc.

Bayer AG

Les Laboratoires Servier

Taiho Pharmaceutical Co. Ltd.

Bristol Myers Squibb Company

Immutep Ltd.

Regeneron Pharmaceuticals, Inc.

Additional Topics

Clinical Trials ImmunoOncology Strategy Research & Development BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.